Cytogam (CSL Behring AG)
Welcome to the PulseAid listing for the Cytogam drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | CSL Behring AG |
| NON-PROPRIETARY NAME: | Human Cytomegalovirus Immune Globulin |
| SUBSTANCE NAME: | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-01-06 |
| END MARKETING DATE: | 0000-00-00 |
Cytogam PLASMA DERIVATIVE Details:
| Item Description | Cytogam from CSL Behring AG |
| LABELER NAME: | CSL Behring AG |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2009-01-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44206-532_956999c6-95ee-4889-b149-4ab73f43f931 |
| PRODUCT NDC: | 44206-532 |
| APPLICATION NUMBER: | BLA103189 |
Other HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:
